List of insiders holdings for Adamas Pharmaceuticals Inc:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
1 | MDV IX LP Seventh MDV Partners L.L.C. Ninth MDV Partners L.L.C. FEIBER JONATHAN D SCHOENDORF NANCY J MDV ENF VII (A) L.P. MDV ENF VII (B) L.P. MDV VII Leaders' Fund L.P. MDV VII LP 10% Owner |
2018-02-14 13:03:37 | 4,698,796 0 |
4,698,796 | Form 13D |
2 | Went Gregory T Chief Executive Officer |
2020-02-14 16:01:23 | 1,447,441 0 |
1,447,441 | Form 13G |
3 | aeris Capital Equity Investments L.P. 10% Owner |
2016-02-12 09:07:30 | 837,128 0 |
837,128 | Form 13G |
4 | Rimac Anthony M Chief Financial Officer |
2014-04-09 18:34:58 | 260,000 0 |
260,000 | Form 3 |
5 | GREAT POINT PARTNERS LLC JAY JEFFREY R KROIN DAVID 10% Owner |
2017-10-10 16:14:12 | 256,340 0 |
256,340 | Form 13G |
6 | COFFEE MICHAEL DENIS Senior VP, Strategy & Planning |
2014-04-10 15:32:36 | 175,416 0 |
175,416 | Form 3 |
7 | Patni Rajiv Chief Medical Officer |
2019-04-10 16:26:26 | 109,141 0 |
109,141 | Form 4 |
8 | LIEBERBURG IVAN M Director |
2020-06-05 18:45:01 | 63,000 16,000 |
79,000 | Form 4 |
9 | Knapp Jeffrey H Chief Operating Officer |
2015-02-27 17:24:48 | 65,000 0 |
65,000 | Form 4 |
10 | Shin Grace General Counsel |
2014-12-03 19:04:24 | 65,000 0 |
65,000 | Form 4 |
11 | Rhodes Jennifer J CBO, GC & Compliance Officer |
2019-06-21 17:38:30 | 63,114 0 |
63,114 | Form 4 |
12 | KING RICHARD Chief Operating Officer |
2018-06-22 16:47:52 | 48,856 0 |
48,856 | Form 4 |
13 | MERRIWEATHER ALFRED G Chief Financial Officer |
2019-09-23 16:19:22 | 48,019 0 |
48,019 | Form 4 |
14 | McClure Natalie SVP, Product Development |
2016-04-20 17:49:11 | 25,006 0 |
25,006 | Form 4 |
15 | Dier Mardi Director |
2021-06-04 16:13:53 | 20,000 0 |
20,000 | Form 4 |
16 | Lewis Sara Grootwassink Director |
2015-05-18 17:25:28 | 18,000 0 |
18,000 | Form 4 |
17 | BOOTH RICHARD H Director |
2017-06-02 16:40:27 | 15,000 0 |
15,000 | Form 4 |
18 | DAWSON WILLIAM J Chief Financial Officer |
2017-03-22 17:02:41 | 14,284 0 |
14,284 | Form 4 |
19 | DAG Ventures Management III LLC DAG VENTURES III-QP LP DAG Ventures III L.P. DAG Ventures GP Fund III LLC Cadeddu John J. Goodrich R. Thomas 10% Owner |
2016-02-10 06:10:07 | 0 0 |
0 | Form 13G |
20 | MacPhee John A Director |
2021-11-24 16:07:50 | 0 0 |
0 | Form 4 |
21 | DEMSKI MARTHA J Director |
2021-11-24 16:08:14 | 0 0 |
0 | Form 4 |
22 | RICHO ANNA Director |
2021-11-24 16:08:47 | 0 0 |
0 | Form 4 |
23 | Papapetropoulos Spyridon Director |
2021-11-24 16:09:09 | 0 0 |
0 | Form 4 |
24 | Shreedhar Vijay Chief Commercial Officer |
2021-11-24 16:09:36 | 0 0 |
0 | Form 4 |
25 | Ericson William W. Director 10% Owner |
2021-11-24 16:09:56 | 0 0 |
0 | Form 4 |
26 | Prentiss Christopher B Chief Financial Officer |
2021-11-24 16:10:18 | 0 0 |
0 | Form 4 |
27 | McFarlane Neil F. Chief Executive Officer |
2021-11-24 16:10:40 | 0 0 |
0 | Form 4 |
28 | MAHONEY DAVID L Director |
2021-11-24 16:11:16 | 0 0 |
0 | Form 4 |
29 | BIGHAM MICHAEL Director |
2021-11-24 16:11:37 | 0 0 |
0 | Form 4 |